Vascular & Endovascular

A 34-year-old stroke patient was stuck with a bill for nearly a half-million dollars after taking a flight from Wichita, Kansas, to Boston to see a neurosurgeon.

Patients with diabetes and peripheral artery disease (PAD) are significantly more likely than nondiabetics with PAD to die from cardiovascular causes or have a heart attack or stroke, according to a subanalysis of the EUCLID trial.

The FDA is requiring all manufacturers of fluoroquinolones—a popular class of antibiotics—to warn about the risk of aortic aneurysm and dissection associated with the drugs in their prescribing information and patient medication guides.

Hospitals participating in a quality improvement program were 7.3 times more likely to administer IV alteplase within one hour of a stroke patient’s arrival in 2017 versus 2008, according to a study published Dec. 17 in Circulation: Cardiovascular Quality and Outcomes.

Regardless of a woman’s smoking status, her BMI or whether she has any cardiovascular comorbidities, giving birth to at least one child raises her risk of developing heart disease or stroke by 16 percent, according to research out of Tongji Medical College in Wuhan, China.

White women—but not black women—between the ages of 65 and 74 carried a lower risk of stroke than their male counterparts in a U.S. study, suggesting gender-specific protections against stroke vanish earlier among blacks.

Low-dose vaginal estrogen therapy—a treatment used to relieve genital and urinary discomfort in women during menopause—isn’t associated with an elevated risk of cardiovascular disease or cancer, researchers reported in Menopause Dec. 17.

Several professional societies collaborated to release appropriate use criteria for peripheral artery intervention (PAI), a field the authors acknowledged still has an emerging evidence base that is likely to change these recommendations in the future.

The FDA has granted premarket approval to Cardiva Medical’s vascular closure system for use during electrophysiology procedures such as cardiac ablation and left atrial appendage closure, the company announced Dec. 18.

Two trials designed to test the use of drug-eluting devices in patients with peripheral artery disease (PAD) were halted soon after a meta-analysis linked paclitaxel-coated balloons and stents to a significantly increased risk of death beyond one year post-implantation.

Kettering General Hospital in Northamptonshire, England, is now one of the few heart centers in the world using Shockwave Medical’s intravascular lithotripsy (IVL) system to treat calcified arteries, the hospital announced after its first successful procedure on Nov. 16.

A report issued Dec. 14 by the Campaign for Tobacco-Free Kids, American Heart Association and Truth Initiative, among other public health groups, ranked Alaska No. 1 in the nation for funding programs that protect high-school aged kids against tobacco use and help current smokers quit.